Literature DB >> 21901631

Mycobacterial infections in adult patients with hematological malignancy.

C-Y Chen1, W-H Sheng, C-C Lai, C-H Liao, Y-T Huang, W Tsay, S-Y Huang, J-L Tang, H-F Tien, P-R Hsueh.   

Abstract

We retrospectively analyzed the clinical and microbiological characteristics of adult patients with hematological malignancy and nontuberculous mycobacteria (NTM) infections from 2001 to 2010. During the study period, 50 patients with hematological malignancy and tuberculosis (TB) were also evaluated. Among 2,846 patients with hematological malignancy, 34 (1.2%) patients had NTM infections. Mycobacterium avium-intracellulare complex (13 patients, 38%) was the most commonly isolated species, followed by M. abscessus (21%), M. fortuitum (18%), and M. kansasii (18%). Twenty-six patients had pulmonary NTM infection and eight patients had disseminated disease. Neutropenia was more frequently encountered among patients with disseminated NTM disease (p = 0.007) at diagnosis than among patients with pulmonary disease only. Twenty-five (74%) patients received adequate initial antibiotic treatment. Five of the 34 patients died within 30 days after diagnosis. Cox regression multivariate analysis showed that chronic kidney disease (p = 0.017) and neutropenia at diagnosis (p = 0.032) were independent prognostic factors of NTM infection in patients with hematological malignancy. Patients with NTM infection had higher absolute neutrophil counts at diagnosis (p = 0.003) and a higher 30-day mortality rate (15% vs. 2%, p = 0.025) than TB patients. Hematological patients with chronic kidney disease and febrile neutropenia who developed NTM infection had significant worse prognosis than patients with TB infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901631     DOI: 10.1007/s10096-011-1407-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Disseminated nontuberculous mycobacterial infection mimic metastases on PET/CT scan.

Authors:  Kuan-Hsiu Lin; Jao-Hsien Wang; Nan-Jing Peng
Journal:  Clin Nucl Med       Date:  2008-04       Impact factor: 7.794

3.  Infections due to nontuberculous mycobacteria in children with leukemia.

Authors:  O Levendoglu-Tugal; J Munoz; A Brudnicki; M Fevzi Ozkaynak; C Sandoval; S Jayabose
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

4.  Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.

Authors:  C-Y Chen; W Tsay; J-L Tang; H-F Tien; Y-C Chen; S-C Chang; P-R Hsueh
Journal:  Epidemiol Infect       Date:  2009-11-27       Impact factor: 2.451

5.  Mycobacterium xenopi: infection in an immunocompromised host.

Authors:  B Damsker; E J Bottone; L Deligdisch
Journal:  Hum Pathol       Date:  1982-09       Impact factor: 3.466

Review 6.  Susceptibility to nontuberculous mycobacterial lung disease.

Authors:  P Sexton; A C Harrison
Journal:  Eur Respir J       Date:  2008-06       Impact factor: 16.671

7.  Non tuberculous mycobacteria (NTM) in patients with underlying diseases: results obtained by using polymerase chain reaction-restriction enzyme analysis between 1997-2002.

Authors:  A Ergin; G Hascelik
Journal:  New Microbiol       Date:  2004-01       Impact factor: 2.479

8.  Nontuberculous mycobacterial infections in pediatric acute leukemia.

Authors:  Kaveri Suryanarayan; James Campbell; Allen E Eskenazi
Journal:  J Pediatr Hematol Oncol       Date:  2002-10       Impact factor: 1.289

9.  Nontuberculous mycobacterial sensitization in the United States: national trends over three decades.

Authors:  Kamran Khan; Jun Wang; Theodore K Marras
Journal:  Am J Respir Crit Care Med       Date:  2007-05-16       Impact factor: 21.405

Review 10.  Nontuberculous mycobacteria in respiratory tract infections, eastern Asia.

Authors:  Sami Simons; Jakko van Ingen; Po-Ren Hsueh; Nguyen Van Hung; P N Richard Dekhuijzen; Martin J Boeree; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

View more
  11 in total

1.  Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients.

Authors:  Ji Young Kang; Jick Hwan Ha; Hye Seon Kang; Hyoung-Kyu Yoon; Hee-Je Kim; Seok Lee; Dong-Gun Lee; Jung Im Jung; Seok Chan Kim; Young Kyoon Kim
Journal:  Int J Hematol       Date:  2015-02-08       Impact factor: 2.490

2.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry can accurately differentiate between Mycobacterium masilliense (M. abscessus subspecies bolletti) and M. abscessus (sensu stricto).

Authors:  Shih-Hua Teng; Chung-Ming Chen; Meng-Rui Lee; Tai-Fen Lee; Kun-Yi Chien; Lee-Jene Teng; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

Review 3.  Nontuberculous mycobacteria infections in immunosuppressed hosts.

Authors:  Emily Henkle; Kevin L Winthrop
Journal:  Clin Chest Med       Date:  2014-12-23       Impact factor: 2.878

4.  Toxicity and adherence to treatment for latent tuberculosis infection in patients with hematologic malignancies.

Authors:  E M Sánchez-García; R Gamallo; A Blanco-Moure; M A Viejo; L Amador; L Anibarro
Journal:  Infection       Date:  2013-06-05       Impact factor: 3.553

Review 5.  Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria.

Authors:  R J Kothavade; R S Dhurat; S N Mishra; U R Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-09       Impact factor: 3.267

Review 6.  Tuberculosis in patients with haematological malignancies.

Authors:  Luis Anibarro; Alberto Pena
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-04-07       Impact factor: 2.576

7.  High recurrence rate supports need for secondary prophylaxis in non-HIV patients with disseminated mycobacterium avium complex infection: a multi-center observational study.

Authors:  Siddharth Sridhar; Kitty S C Fung; Jasper F W Chan; Jimmy Y W Lam; Eric K T Yip; Ivan F N Hung; Alan K L Wu; Tak-Lun Que; Susanna K P Lau; Patrick C Y Woo
Journal:  BMC Infect Dis       Date:  2016-02-10       Impact factor: 3.090

8.  A Case of an Enigmatic Pulmonary Infiltrate.

Authors:  Uroosa Ibrahim; Amina Saqib; Michel Chalhoub; Jean Paul Atallah
Journal:  Cureus       Date:  2016-10-13

9.  Reduced incidence of interstitial pneumonitis after allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation.

Authors:  Yun Chiang; Cheng-Hong Tsai; Sung-Hsin Kuo; Chieh-Yu Liu; Ming Yao; Chi-Cheng Li; Shang-Yi Huang; Bor-Sheng Ko; Chien-Ting Lin; Hsin-An Hou; Wen-Chien Chou; Jia-Hau Liu; Chien-Chin Lin; Shang-Ju Wu; Szu-Chun Hsu; Yao-Chang Chen; Kai-Hsin Lin; Dong-Tsamn Lin; Hsien-Tang Chou; Meng-Yu Lu; Yung-Li Yang; Hsiu-Hao Chang; Ming-Chih Liu; Xiu-Wen Liao; Jian-Kuen Wu; Sheng-Chieh Chou; Chieh-Lung Cheng; Chien-Yuan Chen; Woei Tsay; Hwei-Fang Tien; Jih-Luh Tang; Yu-Hsuan Chen
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

10.  Differential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood.

Authors:  David M Lowe; Julie Demaret; Nonzwakazi Bangani; Justine K Nakiwala; Rene Goliath; Katalin A Wilkinson; Robert J Wilkinson; Adrian R Martineau
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.